S 3188
Biomanufacturing Excellence Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:30 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Biomanufacturing Excellence Act of 2025 aims to establish a national center of excellence focused on advancing biopharmaceutical manufacturing in the United States. This center will support innovation, improve manufacturing practices, and bolster the biotechnology workforce. The goal is to reduce reliance on foreign supply chains and strengthen the U.S. position in this critical field by fostering collaboration between public, private, and nonprofit organizations. Ultimately, the act seeks to accelerate the development and production of life-saving medicines and therapies.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Thomas Tillis
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.